GSA Capital Partners »

C4 Therapeutics shares owned by GSA Capital Partners

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $398k 49k 8.16
2023-06-30 $858k 312k 2.75
2023-03-31 $556k 177k 3.14
2022-12-31 $86k 15k 5.88
2022-09-30 $175k 20k 8.79
2022-06-30 $168k 22k 7.52